Antiviral Medications for Treatment of COVID Available at Select ShopRite Pharmacies

June 16, 2022
Select ShopRite Pharmacies are dispensing antiviral medicines to customers for the treatment of COVID-19, as part of ShopRite’s ongoing effort to help communities fight the virus.

Antiviral medications such as Pfizer’s Paxlovid and Merck’s Molnupiravir are recommended for those at risk of severe illness from COVID-19, but need to be taken within five days of the onset of symptoms or a diagnosis. Patients who are positive for COVID or experience symptoms of the virus should contact their physician to discuss antiviral medication, which can only be prescribed by a doctor, and who can advise them where they are available.

“We are proud to be part of the effort to help our communities and families fight this virus,” said Harshil Patel, Director of ShopRite Pharmacy. “To date, ShopRite has administered a half million doses of the COVID-19 vaccine, and antiviral medication is another tool we can use to help defeat this disease.”

Last December, the Food and Drug Administration (FDA) authorized the use of Paxlovid and Molnupiravir for patients at high risk of serious illness when testing positive for COVID-19. Clinical trials have shown that these drugs have reduced the risk of hospitalization and death among unvaccinated people who contract COVID-19.

<< Back

  • Forgot My Password


  • Media Requests


You must be logged in to view this item.


If you are a member of the new media, please register here.

This area is reserved for members of the news media. If you qualify, please update your user profile and check the box marked "Check here to register as an accredited member of the news media". Please include any notes in the "Supporting information for media credentials" box. We will notify you of your status via e-mail in one business day.